TGFA and pancreatic neoplasm: The ADCs, particularly the ones that contained MMAF, demonstrated a significant antiproliferative effect on TGFα-expressing pancreatic cancer cells, with IC50 values significantly lower than those of the free drug or the unconjugated antibodies.